Eradication of hepatitis C virus with direct‐acting antivirals improves glycemic control in diabetes: A multicenter study

BACKGROUND AND AIM: Hepatitis C virus (HCV) infection causes insulin resistance and diabetes as extrahepatic manifestations. We aimed to analyze the effect of HCV eradication by direct‐acting antiviral (DAA) agents on glucose tolerance. METHODS: The hemoglobin A1c (HbA1c) of 272 patients with HCV in...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Hirokazu, Nakahara, Takashi, Kogiso, Tomomi, Imajo, Kento, Kessoku, Takaomi, Kawaguchi, Takumi, Ide, Tatsuya, Kawanaka, Miwa, Hyogo, Hideyuki, Fujii, Hideki, Ono, Masafumi, Kamada, Yoshihiro, Sumida, Yoshio, Anzai, Keizo, Shimizu, Masahito, Torimura, Takuji, Nakajima, Atsushi, Tokushige, Katsutoshi, Chayama, Kazuaki, Eguchi, Yuichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857302/
https://www.ncbi.nlm.nih.gov/pubmed/33553660
http://dx.doi.org/10.1002/jgh3.12474

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7857302/
https://www.ncbi.nlm.nih.gov/pubmed/33553660
http://dx.doi.org/10.1002/jgh3.12474

Ejemplares similares